The company is targeting a listing on the Australian Securities Exchange. The post Exopharm to Buy Tryp Therapeutics in All-Stock Deal appeared first on...
Filament Health has signed a non-binding term sheet for up to US$14.4 million in funding through a convertible note. The post Filament Health Announces...
Potentially groundbreaking results as Cybin's Phase 2 Study of CYB003 in Major Depressive Disorder showed 79% of patients in remission after two 12mg doses. The...
The firm says its existing cash will fund it through 2025. The post Compass Pathways Research, Clinical Trials Buoyed by Influx of New Funds appeared first...
Christian Antoni Montai Health has kept most of its business under wraps since emerging from stealth last December. But this week the startup hired its...
In breaking news, Beckley Waves announces the acquisition of Nue Life. The post Breaking News: Beckley Waves Acquires Nue Life appeared first on Micro...
Numinus has announced an at-the-market equity offering program that allows the company to issue and sell up to $10,000,000 (CAD) of common shares. The...
The exact number of shares to be sold will be determined by Numinus' financier. The post Numinus to Sell C$10M Worth of New Shares Through Equity...
Condensed Interim Consolidated Financial Statements For The Three and Nine Months Ended July 31, 2023 (Expressed in United States Dollars) (Unaudited)...
Core One Labs Inc. (CSE: COOL), (OTCQB: CLABF), (Frankfurt: LD6, WKN: A3CSSU) (the “Company” or “Core One”) is pleased to announce that it...